China Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon

Bulletin Express06-26 19:43

China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Company Limited.

The latest tranche raised RMB2.00 billion with a three-year maturity and an annual coupon rate of 1.59%. Proceeds are earmarked for production-related expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investments, in accordance with relevant regulations.

The transaction follows two earlier tranches announced on 27 March 2026 and 28 April 2026, bringing the company closer to fulfilling its 2026 bond programme. The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.

The announcement was issued on 26 June 2026 and signed by Chairman Mr. Bai Xiaosong on behalf of the board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1143672213?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 19:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143672213","market":"hk","top_or_hot":-1,"title":"China Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon","media":"Bulletin Express","content":"<p>China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Company Limited.</p>\n<p>The latest tranche raised RMB2.00 billion with a three-year maturity and an annual coupon rate of 1.59%. Proceeds are earmarked for production-related expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investments, in accordance with relevant regulations.</p>\n<p>The transaction follows two earlier tranches announced on 27 March 2026 and 28 April 2026, bringing the company closer to fulfilling its 2026 bond programme. The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.</p>\n<p>The announcement was issued on 26 June 2026 and signed by Chairman Mr. Bai Xiaosong on behalf of the board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-26 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Company Limited.</p>\n<p>The latest tranche raised RMB2.00 billion with a three-year maturity and an annual coupon rate of 1.59%. Proceeds are earmarked for production-related expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investments, in accordance with relevant regulations.</p>\n<p>The transaction follows two earlier tranches announced on 27 March 2026 and 28 April 2026, bringing the company closer to fulfilling its 2026 bond programme. The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.</p>\n<p>The announcement was issued on 26 June 2026 and signed by Chairman Mr. Bai Xiaosong on behalf of the board.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"","article_id":"1143672213","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143672213","pubTimestamp":1782474198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药"},"translate_title":"华润医药完成2026年第三期20.0亿元公司债券发行，票面利率为1.59%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1},"content_text":"China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Company Limited.\nThe latest tranche raised RMB2.00 billion with a three-year maturity and an annual coupon rate of 1.59%. Proceeds are earmarked for production-related expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investments, in accordance with relevant regulations.\nThe transaction follows two earlier tranches announced on 27 March 2026 and 28 April 2026, bringing the company closer to fulfilling its 2026 bond programme. The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.\nThe announcement was issued on 26 June 2026 and signed by Chairman Mr. Bai Xiaosong on behalf of the board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1143672213","isCrawlerRequest":true}